Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Fycompa® (perampanel) – Expanded indication
September 28, 2018 - Eisai announced the FDA approval of Fycompa (perampanel), for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older.
